| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3041458 | Clinical Neurology and Neurosurgery | 2011 | 4 Pages |
Abstract
Patients in Birmingham are diagnosed with GBM more rapidly than those in Strasbourg but they have poorer survival. Differences in disease severity may partially account for the observed results and further large scale work is required to support this study.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Ammar Natalwala, Viren Bharkhada, Georges Noel, Garth Cruickshank,